← Leaderboards
Michael P McDonald
Vanderbilt University
$8,022,098
Attributed
$9,009,586
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,009,586 · 10
By mechanism
R01$7,441,664 · 6
R21$1,567,922 · 4
Top collaborators
- Francesca-Fang Liao7 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Conrad Wagner$6,130,994
- Donald W Horne$506,886
- L Jackson Roberts$17,065,377
- Mark J Koury$148,853
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainNeurotoxicityNeuropathologyCell DeathImpaired CognitionAmyloidS DiseaseMouse ModelEventTreatment StrategyPreventTransgenic MiceMemory ImpairmentNerve DegenerationPositioning AttributeBaseCognitionOxidative StressNeurochemistryNeurobehavioral ManifestationsBiologicalBehavioralMemory
Grant awards (30)
Effects of glycomacropeptide on memory and Alzheimer-related neuropathology$380,000
R01 · FY2020 · AG · contact PI
Effects of glycomacropeptide on memory and Alzheimer-related neuropathology$380,000
R01 · FY2019 · AG · contact PI
Effects of modified erythropoietin on cognition and neuropathology$380,606
R01 · FY2018 · NS · contact PI
Effects of glycomacropeptide on memory and Alzheimer-related neuropathology$380,000
R01 · FY2018 · AG · contact PI
Effects of modified erythropoietin on cognition and neuropathology$384,046
R01 · FY2017 · NS · contact PI
Effects of glycomacropeptide on memory and Alzheimer-related neuropathology$380,000
R01 · FY2017 · AG · contact PI
Effects of intracranial rAAV.Neu3 on dementia and neuropathology$190,000
R21 · FY2017 · AG · contact PI
Effects of modified erythropoietin on cognition and neuropathology$390,137
R01 · FY2016 · NS · contact PI
Effects of intracranial rAAV.Neu3 on dementia and neuropathology$228,000
R21 · FY2016 · AG · contact PI
GD3S knockdown to improve cognitive and motor deficits in models of parkinsonism$306,171
R01 · FY2013 · NS · contact PI
GD3 synthase gene therapy to improve memory and prevent neurodegeneration$290,588
R01 · FY2013 · AG · contact PI
Dietary glycomacropeptide (GMP) for neuroprotection and cognitive enhancement$177,188
R21 · FY2013 · AG · contact PI
AD pathogenesis in a novel mouse diet model with a partial eNOS deficiency$177,188
R21 · FY2013 · AG
GD3S knockdown to improve cognitive and motor deficits in models of parkinsonism$317,275
R01 · FY2012 · NS · contact PI
GD3 synthase gene therapy to improve memory and prevent neurodegeneration$307,500
R01 · FY2012 · AG · contact PI
AD pathogenesis in a novel mouse diet model with a partial eNOS deficiency$225,000
R21 · FY2012 · AG
Dietary glycomacropeptide (GMP) for neuroprotection and cognitive enhancement$211,920
R21 · FY2012 · AG · contact PI
GD3S knockdown to improve cognitive and motor deficits in models of parkinsonism$317,275
R01 · FY2011 · NS · contact PI
GD3 synthase gene therapy to improve memory and prevent neurodegeneration$306,646
R01 · FY2011 · AG · contact PI
Chronic sialidase effects on amyloid aggregation and associated pathology$460,676
R01 · FY2010 · AG · contact PI
GD3S knockdown to improve cognitive and motor deficits in models of parkinsonism$320,513
R01 · FY2010 · NS · contact PI
Chronic sialidase effects on amyloid aggregation and associated pathology$484,452
R01 · FY2009 · AG · contact PI
GD3S knockdown to improve cognitive and motor deficits in models of parkinsonism$322,474
R01 · FY2009 · NS · contact PI
GD3S knockdown to improve cognitive and motor deficits in models of parkinsonism$156,420
R01 · FY2009 · NS · contact PI
Activity effects on Alzheimer neuropathology & dementia$289,005
R01 · FY2006 · AG · contact PI
Activity effects on Alzheimer neuropathology &dementia$295,960
R01 · FY2005 · AG
Activity effects on Alzheimer neuropathology &dementia$295,960
R01 · FY2004 · AG
Gene discovery in a putative mouse model of ADHD$179,313
R21 · FY2004 · NS
Activity effects on Alzheimer neuropathology &dementia$295,960
R01 · FY2003 · AG
Gene discovery in a putative mouse model of ADHD$179,313
R21 · FY2003 · NS